Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.16B |
| 2 |
Bank of America
BAC
|
+$855M |
| 3 |
Comcast
CMCSA
|
+$620M |
| 4 |
Amazon
AMZN
|
+$505M |
| 5 |
Micron Technology
MU
|
+$486M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$441M |
| 2 |
Palo Alto Networks
PANW
|
+$300M |
| 3 |
Verizon
VZ
|
+$286M |
| 4 |
Fidelity National Information Services
FIS
|
+$285M |
| 5 |
Stanley Black & Decker
SWK
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.22% |
| 2 | Financials | 6.16% |
| 3 | Industrials | 5.09% |
| 4 | Consumer Discretionary | 4.89% |
| 5 | Healthcare | 4.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1526
CALL
Monster Beverage
MNST
$91.1B
| $11M | 0.01% |
695,600
+112,800
| +19% | +$1.69M |
|
1527
Global Payments
GPN
$24.6B
| $11M | 0.01% |
109,597
+44,589
| +69% | +$4.46M |
|
|
EXPR
1528
DELISTED
Express, Inc.
EXPR
| $11M | 0.01% |
54,100
+3,060
| +6% | +$502K |
|
|
ETFC
1529
PUT
DELISTED
E*Trade Financial Corporation
ETFC
| $11M | 0.01% |
221,500
+88,100
| +66% | +$4.04M |
|
1530
CALL
Steel Dynamics
STLD
$36.8B
| $11M | 0.01% |
254,500
+75,900
| +42% | +$2.92M |
|
|
SYNH
1531
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $11M | 0.01% |
251,357
+138,235
| +122% | +$6.46M |
|
|
USG
1532
CALL
DELISTED
Usg
USG
| $10.9M | 0.01% |
283,900
+78,200
| +38% | +$2.75M |
|
|
FITB
1533
PUT
Fifth Third Bancorp
FITB
$52.8B
| $10.9M | 0.01% |
360,500
+152,700
| +73% | +$4.45M |
|
1534
CALL
Elevance Health
ELV
$87.1B
| $10.9M | 0.01% |
48,600
-9,800
| -17% | -$2.09M |
|
1535
CALL
Vertex Pharmaceuticals
VRTX
$129B
| $10.9M | 0.01% |
72,900
-29,900
| -29% | -$4.43M |
|
|
SCHW
1536
PUT
Charles Schwab
SCHW
$192B
| $10.9M | 0.01% |
212,400
+66,500
| +46% | +$3.12M |
|
|
VIAB
1537
PUT
DELISTED
Viacom Inc. Class B
VIAB
| $10.9M | 0.01% |
354,100
+84,700
| +31% | +$2.3M |
|
1538
American Financial Group
AFG
$12.1B
| $10.9M | 0.01% |
100,430
+63,895
| +175% | +$6.71M |
|
|
OCLR
1539
DELISTED
Oclaro Inc.
OCLR
| $10.9M | 0.01% |
1,616,487
-1,647,243
| -50% | -$12.2M |
|
1540
Pacira BioSciences
PCRX
$916M
| $10.9M | 0.01% |
238,567
+177,445
| +290% | +$7.03M |
|
|
STMP
1541
CALL
DELISTED
Stamps.com, Inc.
STMP
| $10.9M | 0.01% |
57,900
-12,800
| -18% | -$2.47M |
|
1542
Cheniere Energy
LNG
$55.9B
| $10.9M | 0.01% |
202,033
-22,789
| -10% | -$1.1M |
|
1543
CALL
ProShares UltraPro S&P 500
UPRO
$5.82B
| $10.9M | 0.01% |
465,600
+177,600
| +62% | +$3.82M |
|
1544
ACI Worldwide
ACIW
$5.36B
| $10.9M | 0.01% |
479,502
-95,725
| -17% | -$2.22M |
|
1545
CALL
iShares MSCI South Korea ETF
EWY
$27.8B
| $10.9M | 0.01% |
145,000
-35,100
| -19% | -$2.6M |
|
1546
Belden
BDC
$5.32B
| $10.9M | 0.01% |
140,767
+108,569
| +337% | +$8.97M |
|
1547
Acadia Healthcare
ACHC
$2.85B
| $10.9M | 0.01% |
332,821
+199,090
| +149% | +$6.9M |
|
|
WW
1548
PUT
DELISTED
WW International
WW
| $10.8M | 0.01% |
245,000
+28,500
| +13% | +$1.3M |
|
|
MTOR
1549
CALL
DELISTED
MERITOR, Inc.
MTOR
| $10.8M | 0.01% |
461,200
+279,500
| +154% | +$7.02M |
|
|
BZUN
1550
PUT
Baozun
BZUN
$167M
| $10.8M | 0.01% |
342,800
+279,700
| +443% | +$9.03M |
|
Similar funds
Ken Griffin's Q4 2017 Portfolio in Review
As of Q4 2017, Ken Griffin held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Ken Griffin deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 7.2% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.
- Ken Griffin's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
- Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
- Ken Griffin fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
- Ken Griffin's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
- Ken Griffin opened 1,440 new positions and closed 988 in Q4 2017.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $164B.
Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.